Refresher Courses: Hybrid, Molecular and Translational Imaging
RC 1806 - Non-FDG PET tracers in oncologic imaging
Lectures
1
Chairperson's introduction
05:00Michel Eisenblaetter, Detmold / DE
2
PSMA-PET: state-of-the-art and current developments
15:00Daniela Elena Oprea-Lager, Amsterdam / NL
3
FAPI-PET: a new workhorse in oncologic imaging?
--:--Frederik L Giesel, Düsseldorf / DE
4
SSR-PET: imaging of neuroendocrine tumours and beyond
15:00Luigi Aloj, Cambridge / UK
5
Panel discussion: When and how? Choosing the right tracer for the right patient
10:00Panel discussion: When and how? Choosing the right tracer for the right patient
5 min
Chairperson's introduction
Michel Eisenblaetter, Detmold / Germany
15 min
PSMA-PET: state-of-the-art and current developments
Daniela Elena Oprea-Lager, Amsterdam / Netherlands
1. To become familiar with the development of the PSMA-PET tracers.
2. To get insight into the different radiolabelled PSMA-PET tracers.
3. To assess the rationale of PSMA theranostics in prostate cancer
2. To get insight into the different radiolabelled PSMA-PET tracers.
3. To assess the rationale of PSMA theranostics in prostate cancer
15 min
FAPI-PET: a new workhorse in oncologic imaging?
Frederik L Giesel, Heidelberg / Germany
1. To learn about the radiopharmaceutical basics of FAPI-PET imaging.
2. To learn about current clinical and scientific applications of FAPI-PET imaging.
3. To discuss ongoing developments and future directions.
2. To learn about current clinical and scientific applications of FAPI-PET imaging.
3. To discuss ongoing developments and future directions.
15 min
SSR-PET: imaging of neuroendocrine tumours and beyond
Luigi Aloj, Cambridge / United Kingdom
1. To learn about the radiopharmaceutical basics of SSR-PET imaging.
2. To learn about current clinical and scientific applications of SSR-PET imaging.
3. To discuss ongoing developments and future directions.
2. To learn about current clinical and scientific applications of SSR-PET imaging.
3. To discuss ongoing developments and future directions.
10 min
Panel discussion: When and how? Choosing the right tracer for the right patient